Education, Science, Technology, Innovation and Life
Open Access
Sign In

Advances in Traditional Chinese Medicine Prevention and Treatment of Contrast Nephropathy

Download as PDF

DOI: 10.23977/medcm.2022.040810 | Downloads: 13 | Views: 400

Author(s)

Fan Qu 1, Ping Fan 1

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang 712046, China

Corresponding Author

Ping Fan

ABSTRACT

With the continuous development and wide use of modern imaging technology and the increasing number of interventional procedures, contrast-induced nephropathy (CIN) has become one of the important causes of acquired acute kidney injury, a widespread concern. In recent years, clinical research results show that traditional Chinese medicine also has a certain effect in the prevention and treatment of CIN. This paper summarizes the research progress of traditional Chinese medicine on the prevention and treatment of CIN and provides new research ideas for the further development of traditional Chinese medicine-related drugs for the prevention and treatment of CIN.

KEYWORDS

Contrast Agent Nephropathy, Traditional Chinese Medicine, Prevention and treatment, Review

CITE THIS PAPER

Fan Qu, Ping Fan, Advances in Traditional Chinese Medicine Prevention and Treatment of Contrast Nephropathy . MEDS Chinese Medicine (2022) Vol. 4: 73-79. DOI: http://dx.doi.org/10.23977/medcm.2022.040810.

REFERENCES

[1] Isaka, Y., et al. (2020) Guideline on the Use of Iodinated Contrast Media in Patients with Kidney Disease 2018. Japanese journal of radiology, 38(1): 3-46.
[2] Duan, P., Zhang, X.Y. and Zhang, S.D. (2016) The Effect of High-Dose Atorvastatin Sequential Therapy on Perioperative Contrast-Induced Nephropathy in Patients with Acute Non-ST-Segment Elevation Myocardial Infarction.Chinese Journal of Arteriosclerosis, 24(07):711-714.
[3] Ozkok, S. and Ozkok, A. (2017) Contrast-Induced Acute Kidney Injury: A Review of Practical Points. World journal of nephrology, 6(3): 86-99.
[4] Martin, T., Peter, A. and Norbert, L. (2006) Contrast-Induced Nephropathy. Circulation, 113(14): 1799-1806.
[5] Sun, Y.Q., Miao, S.M., Pan, C., Wen, A.P. and Shen, S. (2021) Quality Evaluation of Clinical Practice Guidelines and Expert Consensus on Contrast Media Nephropathy. China Pharmaceutical, 30(24):107-112.
[6] Yu, J., Xiao, H. and Liu, Y. (2021) Correlation between the Distribution of TCM Syndrome Types and Contrast-Induced Nephropathy after Coronary Intervention. China Emergency Medicine, 30(02):227-229+277.
[7] Gong, X.Z. (2012) Treating Contrast Agent Nephropathy from the Perspective of "Toxicity and Blood Stasis". Shanghai Journal of Traditional Chinese Medicine, 46(02):57-59.DOI:10.16305/j.1007-1334.2012.02.016.
[8] Zhang, Y.L. and Zhou, L. (2017) A Clinical Control Study of Yishen Granule and Xuebijing in the Prevention and Treatment of Contrast Agent Renal Damage. Inner Mongolia Traditional Chinese Medicine, 36(01):12-13. DOI:10.16040/j.cnki .cn15-1101.2017.01.011.
[9] Zhang, Z. (2021) The Preventive Effect of Danhong Injection on Contrast Nephropathy in Patients with Blood Stasis Type Congestive Heart Failure. Hubei University of Traditional Chinese Medicine. DOI: 10.27134/d.cnki.ghbzc. 2021.000355.
[10] Huang, Y.J, Liu, J.Y., Zhan, Q.Z., et al. (2021) A Network Meta-Analysis of the Preventive Effect of Different Traditional Chinese Medicine Injections for Promoting Blood Circulation and Removing Blood Stasis Combined with Conventional Hydration on Contrast Media Nephropathy.Chinese General Practice Medicine , 24(18): 2318-2330.
[11] Liu, D., Zhang, H.S., Sha, F., et al. (2022) The Preventive Effect of Shenkang Injection on Contrast Nephropathy after Peripheral Arterial Intervention. World Journal of Integrative Medicine, 17(09): 1864-1867.DOI:10. 13935/j.cnki.sjzx.220934.
[12] Kong, B.H., Su, Q., Ye, Z.L. and Li, L. (2018) Clinical Efficacy of Trimetazidine Combined with Danshen Ligustrazine Injection on Contrast Nephropathy in Patients with Unstable Angina Pectoris. Chinese Journal of Evidence-Based Cardiovascular Medicine, 10(12): 1466-1470.
[13] Yao, X., Li, N., Gu, X., Han, Z.M. and Long, H.J. (2016) Study on the Preventive Effect of Ligustrazine on Contrast Nephropathy after Percutaneous Coronary Intervention. Modern Journal of Integrative Chinese and Western Medicine, 25(35): 3942-3944.
[14] Huang, Y.J., Liu, J.Y., Zhan, Q.Z., et al. (2021) A Network Meta-Analysis of the Preventive Effect of Different Traditional Chinese Medicine Injections for Promoting Blood Circulation and Removing Blood Stasis Combined with Conventional Hydration on Contrast Medium Nephropathy. Chinese General Practice Medicine, 24(18): 2318-2330.
[15] Chen, Y.J., Chen, Y.K. and Xu, W.C. (2021) Efficacy Observation of Shenmai Injection on Renal Protection in Patients with Coronary Heart Disease after Stenting. Zhejiang Journal of Traditional Chinese Medicine, 56(09):684-685.DOI:10.13633/j.cnki .zjtcm.2021.09.042.
[16] Lu, K.D., Shao, M.X., Ma, H.Z., et al. (2014) Clinical Observation of Xiaoyu Xiezhuo Decoction in the Treatment of Chronic Kidney Disease with Qi Deficiency and Blood Stasis Syndrome. Journal of Zhejiang University of Traditional Chinese Medicine, 38(06): 718-721.DOI:10.16466/j.issn1005-5509.2014.06.010.
[17] Chen, Y.N., Lin, B., Ruan, X.F. and Chen, L. (2021) Clinical Study of Xiaoyu Xiezhuo Decoction in the Prevention of Contrast Agent Nephropathy. Strait Pharmacy, 33(03):166-168.
[18] Xi, Y.T., Yuan, L.Y., Xu, S.T., Liu, X.Y. and Wu, W. (2019) Meta-analysis of the Efficacy of Salvia Polyphenolate Intravenous Drip Combined with Hydration in the Prevention of Contrast Media Nephropathy. China Journal of Traditional Chinese Medicine, 44(12):2616-2626. DOI: 10.19540/j.cnki.cjcmm.20190220.002.
[19] Wu, Q. (2020) Clinical Study of Jiahua Tablets in Preventing and Treating Contrast Nephropathy after Coronary Angiography or Interventional Therapy. Nanjing University of Traditional Chinese Medicine. DOI: 10.27253/d. cnki.gnjzu.2020.000340.
[20] Xu, Z.C. (2022) The Mechanism of Hollyhocks Regulating ROS-ASK1-Mapks Signaling Pathway to Reduce Iopromide-Induced Cell Damage. Nanjing University of Traditional Chinese Medicine. DOI: 10.27253/d.cnki.gnjzu. 2022.000518. 
[21] Pan, J.Z., Meng, Q.L., Cui, W.Y. and Zhu, S.J. (2011) Research Progress on Functional Components and Pharmacological Effects of Chinese Yam. Food Industry Science and Technology: 1-15. DOI: 10.13386/j. issn1002-0306.2022010212.
[22] Fan, X.Y., Hou, Y.J., Jia, S.Y., et al. (2021) Research Progress on the Chemical Constituents of Chinese Yam and Pharmacological Effects of Saponins. Chinese Medicine Information, 38(09):79-84. DOI: 10.19656/j.cnki. 1002-2406. 20210915.
[23] Ma, C.Y., Wang, Y.H., Yang, M. and Cheng, X.D. (2019) Pharmacological Mechanism and Clinical Application of Rhizoma Imperatae and Its Extracts. Medical Review, 25(02):370-374.
[24] Jiang, H.Y. (2021) The Chemical Constituents of Rhizoma Imperatae and Its Anti-Inflammatory Activity in Vitro. Tianjin University of Traditional Chinese Medicine. DOI: 10.27368/d.cnki.gtzyy.2021.000520.
[25] Ding, R. (2020) Effects of Chinese Yam and Rhizoma Imperatae on the Expression of Bcl-2 and Caspase-3 in the Kidney of Rats with Contrast Nephropathy. Hunan University of Traditional Chinese Medicine. DOI:10.27138/d. cnki. ghuzc.2020.000311.

Downloads: 3866
Visits: 153379

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.